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Original Article
Hybrid PET/MRI imaging in healthy
unsedated newborn infants with
quantitative rCBF measurements
using 15O-water PET
Julie B Andersen1, Ulrich Lindberg1, Oline V Olesen1,2,
Didier Benoit1, Claes N Ladefoged1, Henrik BW Larsson1,
Liselotte Højgaard1, Gorm Greisen3 and Ian Law1
Abstract
In this study, a new hybrid PET/MRI method for quantitative regional cerebral blood flow (rCBF) measurements in
healthy newborn infants was assessed and the low values of rCBF in white matter previously obtained by arterial spin
labeling (ASL) were tested. Four healthy full-term newborn subjects were scanned in a PET/MRI scanner during natural
sleep after median intravenous injection of 14MBq 15O-water. Regional CBF was quantified using a one-tissue-compart-
ment model employing an image-derived input function (IDIF) from the left ventricle. PET rCBF showed the highest
values in the thalami, mesencephalon and brain stem and the lowest in cortex and unmyelinated white matter.
The average global CBF was 17.8ml/100 g/min. The average frontal and occipital unmyelinated white matter CBF was
10.3ml/100 g/min and average thalamic CBF 31.3ml/100 g/min. The average white matter/thalamic ratio CBF was 0.36,
significantly higher than previous ASL data. The rCBF ASL measurements were all unsuccessful primarily owing to subject
movement. In this study, we demonstrated for the first time, a minimally invasive PET/MRI method using low activity
15O-water PET for quantitative rCBF assessment in unsedated healthy newborn infants and found a white/grey matter
CBF ratio similar to that of the adult human brain.
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Introduction
The clinical importance of white matter injury or peri-
ventricular leukomalacia (PVL) in the premature infant
has been recognized in neonatal neurology for more
than four decades,1 as a leading cause of long-
term motor and cognitive disability. The etiological
understanding has centered on hypoxic-ischemic and
infectious/inﬂammatory damage, but nutritional and
hormonal factors may also contribute.2 Given that
the white matter is a vascular end-zone and a predom-
inant area for injury in the neonatal patient, knowledge
of the exact quantitative regional cerebral blood ﬂow
(rCBF) value in the healthy newborn can contribute in
understanding the underlying pathophysiology of PVL
in preterm infants.
Measuring rCBF in newborn infants presents sub-
stantial technical and ethical concerns. Regional CBF
in newborn infants is known to be relatively low in
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white matter,3,4 challenging the accuracy of the applied
methods. In addition, the brains of newborn infants are
both smaller and vary in anatomical structure and
tissue maturity including the developmental stage of
myelination when compared to the adult brain.5,6
Quantitative 15O-water PET is considered the ‘gold
standard’ for rCBF measurements in humans7,8 but
existing PET rCBF studies in the neonatal population
are few, and were performed decades ago with a gen-
eration of lower resolution PET scanners and on
infants with neuropathology or suspected neuropathol-
ogy.9–11 Present day state-of-the-art PET imaging
methods have improved signiﬁcantly and may more
appropriately address the technical issues found in
these pioneering studies. Furthermore, there are no stu-
dies in healthy newborns to address what true normal
rCBF values are in this age group.
Although there is a far more accessible and non-
ionizing alternative imaging technique for rCBF meas-
urements than PET in the form of arterial spin labeling
(ASL) using MRI, only a limited number of neonatal
publications are available.12–19 Methodological challenges
for ASL, such as variability of arterial transit time and
obtaining a suﬃcient signal-to-noise ratio, are especially
challenging in the neonatal population with small organs
and generally low rCBF20 and may signiﬁcantly aﬀect
both rCBF distribution and quantitative values.
The purposes of this study was to apply a newly
developed method in healthy newborn subjects using
PET with 15O-water and an image-derived input func-
tion (IDIF) from the left ventricle previously developed
in a piglet model on a hybrid PET/MRI scanner.21
This method utilizes the extended axial ﬁeld of view
of the scanner (25.8 cm) to acquire dynamic data
from both brain and heart simultaneously and obtains
quantitative minimally invasive measures of rCBF with
a radioactive dose suﬃciently low to be acceptable for
medical research in this subject group. PET/MRI
allows simultaneous co-registered CBF measurements
with 15O-water PET and ASL(PASL) MRI allowing
the best possible scenario to estimate accuracy of
CBF values from ASL. This strategy has been used
previously in adults,22 but never in the neonatal
group. We aimed to investigate if the surprisingly low
values of white matter rCBF (3ml/100 g/min) that
have been reported in healthy newborn control subjects
using single TI PASL MRI16,19 could be reproduced
using 15O-water PET. By doing this, we aimed to estab-
lish a proof-of-concept of the new PET/MRI method in
newborn infants. This could be a useful method for
future imaging investigations of preterm infants,
including better understanding of the underlying patho-
physiology and signiﬁcance of changes in rCBF in neo-
natal PVL.
Material and methods
Subjects
Four healthy newborn infants participated in the rCBF
measurements with 15O-water PET and PASL MRI
scans on a hybrid PET/MRI scanner (mMR, Siemens,
Erlangen, Germany). All had an uncomplicated post-
natal period. See Table 1 for details of individual
characteristics.
The newborn infants were recruited one to two days
after birth while hospitalized in the obstetric ward.
Eighty parents were asked to participate and four
families agreed to participate. The main reasons declining
participation by the majority of parents were: (1) prac-
tical issues regarding time and place, (2) possible adverse
eﬀects of radiation exposure to the child and (3) reduced
mental resources to cope with the procedure and scan.
Ethical considerations
According to EU legislation, eﬀective dose limits for
members of the general public have been set to
1 mSv/year in addition to the average annual back-
ground exposure to ionizing radiation 2.4 mSv/year.
Table 1. Subject characteristics.
Subject Gender
Age
(d) Para
GA
(wþd)
Birth
Weight (g) Delivery Apgar
pH
(A/V)
H2
15O
(MBq)
1 M 2 1 40þ 1 3262 Vaginal 10, 10, 10 7.21/7.35 14
2a M 3 3 40þ 1 3664 Vaginal 10, 10, 10 7.33/7.39 15
3 M 3 2 38þ 4 3438 C-section 8, 9, 10b 7.13/7.34 14
4c M 2 1 38þ 2 3246 C-section 10, 10, 10 7.32/7.38 14
aMother with Lub-antibodies with titer 1. Infant with maximum serum-bilirubin level 127. No intervention. b Color and tone. cChild with infrequent eye
contact and delayed eyesight development. Normal eye exam and normal structural external anatomy. Normal development on 1 year clinical follow-
up. GA: gestational age. Note: Para (para gravida): the number of pregnancies. Apgar: the Apgar score of newborn infants at 1, 5, 10min after birth. pH
(A/V): Postpartum umbilical cord arterial and venous pH.
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One mSv/year is also the eﬀective dose limit for special
protection of the unborn child in pregnant workers, e.g.
medical staﬀ, during the pregnancy,23 and the upper
dose limit recommendation set by the International
Commission on Radiological Protection (ICRP) for
‘individuals that are exposed from a single dominant
source that gives them little or no individual beneﬁt
but beneﬁts to society in general’. This dose corres-
ponds to the radiation thresholds deﬁned in the
European Commission guidance on medical exposure
for biomedical research,24 which states that up to
0.1 mSv may be used for research aiming at ‘increasing
knowledge’, while up to 1 mSv may be used for research
aiming at ‘health beneﬁts’. The probability of a fatal
radiation induced cancer has been estimated to
approximately 0.005% per mSv eﬀective dose for the
whole population with its normal age distribution. For
children up to the age of 10 years, the probability of
fatal cancer induction is assumed to be two to three
times higher for safety reasons.23,25 Thus, we set an
upper eﬀective dose limit in this study of 0.33 mSv,
which incidentally is comparable to the background
radiation dose per month for the general public
in Denmark (4.0 mSv/year). This dose corresponds to
an injected activity of 14–15MBq 15O-water per injec-
tion or approximately 4.3MBq/kg to infants with a
mean weight of 3.4 kg. The activity administered to
each child was calculated based on an approximate
weight at scanning which was assumed to be 10%
lower than the birth weight (Table 1).
The study was approved by the Regional Scientiﬁc
Ethical Committee of the Capital Region of Denmark,
protocol no. H-6-2014-081 and oral and written
informed consent was obtained from the children’s par-
ents prior to the examination according to the Helsinki
II declaration.
PET and MRI acquisition
An experienced pediatrician placed a small polyethylene
catheter (24 G) in a vein in the hand or cubital vein.
The child was given a sugary solution orally for pain
relief during the procedure. In the scanner, the infants
were swaddled and slept naturally after feeding. They
were monitored with arterial saturation and electro car-
diogram, displayed on a monitor placed in the control
room. Hearing protection (‘mini-muﬀs’) was placed
over the ears. The head was immobilized by small pillows
on both sides. In the last three subjects, a real-time sur-
veillance system, TCL2,26 with a 3D-camera for monitor-
ing and tracking motion of the head and face was applied
throughout the scan, enabling the parents and staﬀ to
view the child’s movements and evaluate depth of sleep
indirectly. The system is an MRI functional version of
TCL127,28 (see Figure 1 and supplementary materials for
a short video clip of the monitoring feedback).
Figure 1. MRI compatible motion tracking system of subject no. 2. A real-time motion tracker and surveillance system applied for
infants in the PET/MRI scanner with 3D surface images of the face and right hand of the infant (left) and tracking of movements on a
plot (right) with displacement in mm in three directions (right top) and the resulting summed displacement in mm (right bottom). The
arrow points to time of tracer injection. There are rapid head movements with displacements of 5mm during scanning returning to
baseline. This circumstance will not significantly affect rCBF PET measurements, but are detrimental for ASL images.
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For the child without video-monitoring, heart rate
was used as a measure of alertness. Infant no. 3 woke
up 70 s after the tracer had been injected and no ASL
data were obtained.
The infants were imaged using a 16-channel mMR
head-neck array coil. High resolution 3D T1-weighted
imaging (T1w MP-RAGE) was performed for anatom-
ical imaging with the following parameters: Matrix
size¼ 256 256, slice thickness¼ 1mm, echo time
(TE)¼ 2.44ms, TR¼ 1900ms, FOV¼ 250mm, ﬂip
angle 9. In one of four children, 2D T2-weighted
images (BLADE) were acquired subsequently with the
following parameters: Matrix size: 320 320, slice
thickness¼ 5mm, TE¼ 118ms, TR¼ 6000ms, ﬂip
angle 125.
In two of three infants, ASL data acquisition was
performed simultaneously with the PET scan. For the
last infant, the ASL scan was performed immediately
after the PET scan. The change of procedure was done
to avoid audible noise from the MRI during the PET
scanning, which was observed to cause stirring of the
ﬁrst two infants. Pulsed ASL scans lasted 7min and
planning of the sequence was done on the T1w
MP-RAGE. ASL was performed with the standard
Siemens protocol (PICORE-Q2TIPS) (See supplemen-
tary material for imaging parameters of ASL).
Dynamic PET scans were started approximately 60 s
before 14 or 15MBq 15O-water was injected IV by hand
as a short bolus (1–2ml) through an additional tubing
of approximately 75 cm ﬁlled with isotonic saline with a
volume of 1ml. The catheter was immediately ﬂushed
with 2ml isotonic saline. Data were collected in list-
mode for 8min. On T1w MP-RAGE, it was veriﬁed
that both brain and heart were in the axial ﬁeld of
view in all subjects.
MRI-based attenuation maps for PET attenuation
correction (AC) of the brain region were derived
using the vendor provided ultrashort echo time (UTE)
imaging with repetition time/TE 1/TE 2¼ 11.94/0.07/
2.46ms, ﬂip angle 10, reconstructed on 192 192
192 matrices (1.6 1.6 1.6mm3). The PET attenu-
ation maps were created in the following manner: AC
was based on an in-house method called RESOLUTE,
a fully automatic method that segments air, brain, and
soft tissue voxels on the UTE images, and uses a map-
ping of R2 values to Hounsﬁeld units to obtain patient
speciﬁc continuous bone density value.29 The bone
extraction was limited to the head to minimize noise.
Similarly, the lungs were based on a semi-automatic
segmentation method using the R2 signal.
PET data analysis
The PET images were reconstructed using maximum
likelihood estimation method (MLEM) performing
42 iterations with one subset and a voxelsize of
2.1 2.1 2.0mm3. The data were sorted in the follow-
ing manner in subject no. 1 and 2: 1 60 s, 15 2 s,
11 5 s, 12 10 s, 4 20 s, 1 135 s, subject no 3:
1 60 s, 35 2 s, subject no 4: 1 40 s, 15 2 s, 11
5 s, 12 10 s, 4 20 s, 1 155 s. The length of the ﬁrst
frame accounts for the delay between scanner start and
injection time (Figure 2) necessary for sequence initi-
ation. Images were reconstructed with a Gaussian
reconstruction ﬁlter of 2mm and corrected for ran-
doms, dead time and decay. Note that for display pur-
poses, the PET images are shown after a 5mm
Gaussian ﬁltering (Figures 4 and 5).
All PET analysis was done in PMOD (Zu¨rich,
Switzerland). A whole brain region was manually
drawn as a VOI along with a total of 11 regional
VOIs on the T1wMP-RAGE image: frontal and occipi-
tal periventricular unmyelinated white matter, frontal
cortex, occipital cortex, perirolandic cortex, thalamus,
striatum, mesencephalon, pons and medulla and central
myelinated white matter in the corticospinal tracts
above the insula identiﬁed by a higher signal intensity
on the T1-weighted images indicating increased lipid
content (Figure 3). The cortical VOIs followed the
structure boundaries closely. Periventricular white
matter VOIs were drawn approximating on the primar-
ily lesion sites for PVL with a minimum of 4mm dis-
tance to grey matter to avoid activity spill-in.
Measurements were obtained in the right and left side
of the cerebrum. A 1-tissue compartment model
adapted to 15O-water PET studies was applied.
K1(rCBF), k2 and delay were ﬁtted simultaneously as
proposed in Meyer.30 The dispersion was not ﬁtted
but was set to 0 s. The equation is as shown in our
previous report.21 The length of the ﬁt was 180 s from
injection time.
The extended axial ﬁeld-of-view of 25.8 cm of the
scanner allowed for simultaneous coverage of the
whole brain and heart (see Figure 1 in supplementary
material). The IDIF was generated from the dynamic
PET sequence as described in our previous report.21
A box-shaped VOI containing the left ventricle of the
heart was deﬁned on the T1wMP-RAGE and projected
to the summed PET image of the ﬁrst 16 s after bolus
injection ﬁltered by a 3D Gaussian 6mm ﬁlter. Within
this VOI, the 30 voxels (0.26ml) with highest activity
was selected and used to extract the IDIF from the
dynamic PET sequence. On the T1w MP-RAGE, the
positioning of the IDIF VOI was evaluated, with
the placement in the center of the left ventricle at a
distance of a minimum 5mm from the myocardial
wall. The apical length of the left ventricle was average
2.8 cm (range 2.6–3.0 cm) and the diameter of the left
ventricle was average 1.4 cm (range 1.3–1.6) based on
three of the four subjects’ T1w MP-RAGE images.
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Figure 2. Blood and tissue time activity curves. The IDIF time activity curve extracted from a volume of interest in the left ventricle
of the heart (triangles) from subject no. 1. The original IDIF curve is shown without correcting for delay. Tissue activity curve from
frontal and occipital periventricular unmyelinated white matter (circles) and the model fit curve (dots). The tissue activity and IDIF are
shown using different scales.
Figure 3. Axial (a-d) and sagittal (e) images of subject no. 1 documenting volumes-of-interest (VOIs). T1w MP-RAGE MRI is shown
at the top at the level of the basal ganglia (aþb), the centrum semiovale (c), perirolandic cortex (d) and the corpus callosum (e). In (a)
frontal and occipital cortex (yellow and blue) and frontal periventricular unmyelinated white matter (dark green) is displayed. In (b)
thalami (green) and striatum (pink) and frontal unmyelinated white matter (dark green) is shown. In (c) frontal and occipital
unmyelinated white matter (dark green) and myelinated white matter in the centrum semiovale (orange) is shown. In (d) the
perirolandic cortex (blue) is shown. In (e) the cortex from occipital (light blue), frontal (yellow) and perirolandic (blue) is shown. The
PET rCBF images are quantified in ml/100 g/min and displayed after 5mm Gaussian filtering.
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Because of movement artefacts, the left ventricle of the
last subject could not be measured precisely.
Statistical analysis
Regional CBF values from PET are presented as mean
rCBF values, 95% conﬁdence intervals (CI) and coeﬃ-
cient of variation (COV) from the four subjects.
Results
Dynamic PET data were obtained in all four subjects
without sedation. Three subjects had 7-min acquisitions
and one had a 70 s acquisition after tracer injection with
early termination due to movements. The ﬁtted delay in
the four subjects ranged from 0.97 s to 0.38 s with a
mean value of 0.32 s. These values reﬂect the short
distance from the left ventricle to the brain (approxi-
mately 10–15 cm in a term infant) and an accordingly
short time-shift of the tracer from heart to brain (less
than a second). As expected, the ﬁtted delay values vary
within a single frame length (2 s).
All subjects had developmentally normal brain T1w
MP-RAGE images. This includes normal cortical fold-
ing and the expected distribution of increased signal
intensity in the myelinated white matter of the posterior
third of the internal capsules, thalami, mesencephalon
and the central portion of the centrum semiovale.
For anatomical correlation to PET imaging of the
heart, T1w MP-RAGE imaging covered the thorax.
The input curve for the IDIF was obtained from the
left ventricle from all subjects. A plot of the original
IDIF and whole brain tissue curves of subject no. 1 are
shown in Figure 2.
The rCBF PET distribution is shown in Figures 4
and 5, which shows PET with relatively high rCBF in
the striatum, thalami, mesencephalon, pons, cerebellar
vermis, and medulla, and to a lesser degree in the peri-
rolandic cortex, mesial occipital cortex and hippocam-
pal area.
The average quantiﬁed rCBF PET measurements for
periventricular unmyelinated white matter were
10.3ml/100 g/min (range: 9.3–11.5ml/100 g/min). The
whole brain PET CBF values are shown in Table 2.
The average ratio between thalamic rCBF and unmye-
linated white matter was 0.36 (range: 0.24–0.40).
The left hemisphere had a signiﬁcantly higher mean
CBF 10.1ml/100 g/min than the right hemisphere
9.0ml/100 g/min (p¼ 0.01).
The calculations of rCBF ASL in subjects 1 and 2
show areas of high focal CBF related to the position of
known arteries in the insula and the mesial and lateral
Figure 4. Axial rCBF images of four newborn infants (1–4) using PET/MRI. Axial T1w MP-RAGE MRI is shown at the top at the level
of the basal ganglia. The myelination of the white matter is seen in the posterior internal capsule as increased signal intensity (arrow).
The white matter frontally and occipitally has a low signal intensity (arrowheads) indicating low degree of myelination as expected in
imaging of infants at term.45 Infant no 3 only had 70 s PET acquisition. The PET rCBF images are shown after 5mm Gaussian filtering
and quantified in ml/100 g/min. Particularly, high rCBF is found in the striatum and thalami and low rCBF is seen in lateral frontal and
occipital white matter and cortices.
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cortices. In subject 4, there is relatively high cortical
rCBF in the frontal lobes with a defect in the occipital
areas (see supplementary material). In all three subjects,
the distribution of the rCBF ASL values deviated signiﬁ-
cantly from both the simultaneous PET rCBF measure-
ments, and the expected rCBF found in previous ASL
studies16,20 and were, therefore, interpreted as too tech-
nically inadequate and unreliable to analyze further.
No ASL data were obtained in subject 3 because the
infant woke up before scanning.
Discussion
This study is a human implementation of an experimen-
tal set-up for simultaneous rCBF measurements using
15O-water PET and ASL on a hybrid PET/MRI scan-
ner that we have previously employed in piglets.21 In
that study, we documented that reliable whole brain
CBF values could be obtained even at a very low
injected activity of 20MBq 15O-water using an IDIF
from the heart. We found that whole brain CBF ASL
and CBF PET were congruent during baseline but not
during hyperperfusion. The results were, however,
encouraging enough to translate to human studies. In
newborn infants, we expected better quality data
because of larger brain size (brain weight in piglets 3
weeks old 50 g and in newborn infants approximately
350–400 g), particularly in the estimation of white
matter rCBF that could not be segmented reliably in
piglets because of resolution limitations. Furthermore,
the input function derived from the heart should be
valid since the VOI in the heart is of similar size: the
left ventricular long-axis is approximately 2.6 cm in
three week old piglets31 and was measured to be
2.8 cm in three of the four newborn infants in this
study. An important diﬀerence between the present
study and the animal studies was the lack of sedation
in the infants. This circumstance increases the risk of
image degradation due to head movements, but allows
measurement of the native rCBF distribution uninﬂu-
enced by sedatives. Avoiding sedation was safest, but
also a condition for the inclusion of healthy volunteers.
A very low injected activity of 14–15MBq 15O-water
allowed imaging of suﬃcient quality at a radiation
dose low enough to be acceptable for medical research.
Besides corroborating existing estimates of global CBF
in healthy term infants obtained by a range of methods,
each having their own assumptions, we present the ﬁrst
normal rCBF values in this population. As the pre-
sented method relies on an IDIF,21 the new method
cannot be referred to as ‘gold standard’. However,
since PET is based on relative few assumptions, and
since we have explored the sources of error and their
magnitude in a newborn piglet model (e.g. the possible
overestimation due to the noninvasive determination of
the input function), we consider the results reliable. The
use of an IDIF would not aﬀect the rCBF distribution
that is better deﬁned by 15O-water PET than with ASL
MRI due to the longer half-life of 15O-water. The
method is an adaptation of classical rCBF PET
Figure 5. Sagittal rCBF images of four newborn infants (1–4) using PET/MRI. Sagittal T1w MP-RAGE MRI is shown at the top at the
level of the corpus callosum. The PET rCBF images are shown after 5mm Gaussian filtering and quantified in ml/100 g/min. Relatively,
high rCBF is seen on the PET images in the thalami, mesencephalon, pons, cerebellar vermis, and medulla, and to a lesser degree in the
perirolandic cortex.
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methodology using state-of-the-art hardware, and can
serve as a valuable tool for the comparison, evaluation
and optimization of more clinically available methods,
such as ASL MRI in the neonatal population.
Even though we had a low participation rate of
families, we don’t believe this aﬀected the result’s rep-
resentativeness, but rather highlighted the diﬃculties in
recruiting infants to research projects that do not dir-
ectly beneﬁt the parents nor infant.
Since PET inherently involves ionizing radiation, a
pediatric PET research method should be reliable,
quantitative, and ethically and clinically acceptable in
terms of minimal invasiveness and radiation dose, by
complying with the principles of ALARA (‘‘as low as
reasonably achievable’’).32 The level of what is applied
in our study is well within what EU legislation for radi-
ation dose in healthy children. This tracer dose (0.33
mSv per injection in this study) could also be applied in
scientiﬁc protocols in a patient group of infants with
prematurity or neuropathology such as PVL, aiming
directly at the diagnosis, cure, or prevention of dis-
ease.24,25 It should be noted that most data regarding
the absorbed dose estimates of 15O-water in pediatric
patients from ICRP80 are based on adult data.33
15O-water kinetics is simple, and because of the short
half-life of the isotope (122 sec), the radiation dose is
limited. However, when following the present precau-
tionary principle model, one should always carefully
consider the clinical value of a study using ionizing
radiation in pediatric patients.
In the present study, the left ventricle of the heart
could comfortably be contained in the extended axial
FOV of the scanner enabling dynamic sampling of the
IDIF in a large blood volume. The IDIF alleviated the
need for invasive arterial blood sampling while still
enabling a valid quantiﬁcation of rCBF. The IDIF
method for quantitative PET measurements has been
thoroughly investigated in the literature using diﬀerent
approaches to optimize the input curve.34–36 In new-
born infants, only one previous study applied the left
ventricle for IDIF extraction and quantitative glucose
uptake values.37 In our study on piglets, we observed an
overestimation of approximately 20% when compared
to gold standard arterial blood sampling which may in
part be explained by the 3-s time framing used as
opposed to 1 - and 2-s framing giving a better time
resolution and minimizing the underestimation of
the peak of the input curve. We applied 2-s time fram-
ing in the PET data reconstruction of the newborn
infants to minimize this eﬀect. However, since the struc-
tures in question are small (the left ventricle of the heart
is approximately 2mL in a full term neonate38 and
the applied VOI in the left ventricle was 0.26mL), par-
tial volume eﬀects and resolution recovery may inﬂu-
ence the values obtained from the dynamic time
framing leading to an underestimation of the values
in the IDIF. Consequently, there is a possible overesti-
mation of rCBF values in this ﬁrst human study, but
considering that the values in question are relatively
small especially in white matter, the implications for
the conclusions of this study are modest. With present
ASL MRI techniques, quantiﬁed rCBF in white matter
is neither reliable in adults nor neonates owing to the
prolonged arrival time of magnetized blood to the peri-
ventricular watershed areas.39,40 However, use of multi-
delay (TI) ASL approach to quantify both arrival time
and CBF can improve quality of the ASL data,41,42
presumably also in the neonatal patient group.
The normal metabolic development of the brain of
newborn patients with suspected pathology has been
investigated in a limited number of FDG PET stu-
dies.6,43,44 The studies showed increased activity in the
sensorimotor area, basal ganglia and the brainstem. At
birth, myelination of white matter has reached the cor-
tical tracts passing through the centrum semiovale in
the internal capsule and cortical spinal tracts relating to
the sensorimotor cortex. Hence, the myelin is visible on
MRI imaging.5,45 In our PET/MRI study on healthy
subjects, this known myelination pattern was replicated
as high signal intensity changes on T1w MP RAGE
images. Noticeably, increased rCBF could be seen in
the corresponding areas on the PET image (Figure 4)
and in the quantiﬁed rCBF values (Table 2), which cor-
relates to the myelination process in cortical and sub-
cortical areas. This result can be interpreted as an
expression of the known neuro-vascular coupling
between metabolism and tissue perfusion. In line with
these ﬁndings, the frontal and occipital periventricular
unmyelinated white matter, showing low intensity
signal on T1w MPRAGE images, had substantially
lower PET rCBF values (Table 2) with a mean of
10.3ml/100 g/min. This result correlated to the myelin-
ation process in these areas occurring much later
between one and two years of age.5
Previous 15O-water PET studies performed in infants
with neuropathology9–11 were performed in 2D acqui-
sition mode with low spatial PET scanner resolution of
11.7 and 18mm and gave an eﬀective radiation dose of
5.8 mSv for each injection. Reliable quantiﬁcation of
rCBF was challenged by the collection of only a few
arterial blood samples to estimate the input function,
which was not corrected for delay nor dispersion. An
alternative method to avoid direct arterial sampling in
older children has been to use a standard arterial input
function to calculate the rCBF distribution that is
scaled by quantitative global CBF calculated from the
clearance of 15O-water, k2.
46,47 However, our subject
group requires hand held injection for safety reasons
to provide the required control over injected activity
and volume, and the arterial input function shape,
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delay and dispersion in infants have not yet been ade-
quately described. These assumptions may be avoided
using an IDIF method based on actual measurements.
As the proposed method is dependent on the inclusion
of both brain and heart in the extended axial ﬁeld of
view of the PET/MRI scanner, this option will only be
feasible until the age of nine months to one year,
depending on the height of the child and with the
ﬁeld of view of the current clinically available PET/
MRI scanner.
None of the aforementioned PET imaging studies9–11
could give reliable estimates of white matter rCBF,
because of the poor resolution of the scanners, but all
have indicated that the white matter rCBF is very low in
newborn infants and that the ratio to basal ganglia CBF
may be as low as 0.23 when measured with SPECT.3 We
found a mean CBF ratio of white matter to the thalami
of 0.36 which is in the range of values measured in the
adult brain (0.30–0.48).48–51 Regional CBF values from
previous studies on term infants with varying degree of
neuropathology, ranged from 9 to 76ml/100 g/
min.9,10,52 The large variation may be caused by the
above-mentioned methodological inadequacies, the
eﬀects of pathology, and the developmental span.53
Global CBF in premature infants measured with
133Xenonwas 20ml/100 g/ml in non-distressed infants.54
Regional CBF in white matter has not been reported
previously with modern PET methods in healthy new-
born infants. Regional CBF using ASL MRI in peri-
ventricular unmyelinated white matter in healthy
infants12,16 has been measured to be between 2.3 and
3.6mL/100ml/min or 1/10 of basal ganglia rCBF,
which is outside the 95% CIs found in this PET study
of 10.3mL/100ml/min (95% CI 8.8;11.7mL/100ml/
min) and 1/3 of thalami rCBF (ratio, 0.36, 95% CI
0.23;0.48). The ASL rCBF values are critically depend-
ent on arrival time of magnetically labeled inﬂowing
arterial blood to the tissue, and delayed arrival can be
the cause of falsely reduce rCBF.55,56 Unfortunately,
our own ASL data could not be used to further illu-
minate the matter. At the time of our studies, the ASL
MRI sequence available to us was a single TI pulsed
ASL (pASL) sequence. Our assumption was that we
could obtain better ASL image quality and data in
the larger brains of the infants than in the piglet
study by our group.21 Motion artefacts are however a
problem for ASL in this age group: 25% of scans were
discarded because of poor image quality in the study by
Boudes et al.20 and 40% in the study by Miranda
et al.15 Unfortunately, the ASL scans of all our subjects
were substantially aﬀected by motion artefacts as docu-
mented with the on-line marker-less tracking system
(Figure 1) and must be considered unreliable. In a clin-
ical setting where sedation is permissible for diagnostic
imaging, motion artefacts could be less signiﬁcant. It
would, however, be preferable to avoid sedation and
correct for movement.27 For subject no. 1 and 2,
there was a pronounced vascular signal that could be
attributed to insuﬃciencies in sequence parameters or
the sequence itself. Comparative studies in newborns
have recommended pseudo-continuous arterial spin
labeling (pCASL) as the superior technique that
Table 2. Quantified regional CBF results.
rCBF (ml/100 g/min) Subject 1 Subject 2 Subject 3 Subject 4 Mean (95% CI) COV (%)
White matter unmyelinated 10.1 11.5 10.1 9.3 10.3 (8.8;11.7) 8.9
White matter myelinated 23.3 15.9 14.6 10.6 16.1 (7.6;24.5) 32.9
Frontal cortex 15.7 12.9 9.3 10.7 12.2 (7.7;16.6) 23.0
Occipital cortex 18.4 16.3 13.2 12.3 15.1 (10.6;19.5) 18.7
Striatum 55.9 24.9 34.1 33.3 37.1 (16.0;58.1) 35.7
Thalamus 42.9 30.3 29.3 22.5 31.3 (17.7;44.8) 27.2
Mesencephalon 52.8 37.8 43.3 47.7 45.4 (35.2;55.6) 14.1
Pons 48.5 35.0 38.4 43.6 41.4 (32.0;50.8) 14.3
Medulla 57.2 38.8 47.7 53.9 49.4 (36.5;62.3) 16.4
Perirolandic cortex 33.2 18.4 13.9 14.2 19.7 (6.0;33.4) 43.7
Right hemisphere 12.4 7.2 8.7 7.5 9.0 (5.1;12.8) 26.7
Left hemisphere 13.4 8.2 9.6 9.3 10.1 (6.5;13.7) 22.4
Whole brain 22.2 17.8 16.2 15.0 17.8 (13;23) 17.7
Ratio white matter/thalami 0.24 0.38 0.40 0.41 0.36 (0.23;0.48) 22.2
Note: Regional CBF, mean, 95% confidence intervals (CI) and coefficient of variation in percent (COV) of four newborn infants scanned on the hybrid
PET/MRI system with 15O-water PET. Values in mL/100 g/min. Ratio is the ratio between rCBF of unmyelinated white matter and thalami. In subject no
3, the PET values were fitted over 70 s, where the other three PET scans were fitted over 180 s. COV: coefficient of variation; rCBF: regional cerebral
blood flow.
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allowed improved image quality with a more detailed
identiﬁcation of the diﬀerent brain structures20 in
accordance with the ASL white paper recommenda-
tions.57 Furthermore, as mentioned previously multide-
lay (TI), ASL could improve quality of the data41,42
especially in low CBF areas (see supplementary mater-
ial for ASL rCBF images of the subjects).
Interruption of the supply of nutrients and oxygen-
ation can cause PVL in vulnerable areas of the periven-
tricular white matter. Assessing changes in perfusion in
white matter is of value in the clinical work-up of PVL
patients and cannot be easily assessed with clinically
available methods (near infrared spectroscopy (NIRS)
and Doppler ultrasound). For this reason, the imple-
mentation of a PET imaging technique with high
spatial resolution could possibly be of importance in
evaluating the severity of PVL. As a one-stop scan,
PET alongside advanced MRI in a PET/MRI could
potentially add to the value of imaging for predicting
severe neurodevelopmental deﬁcits such as debilitating
cerebral palsy.58 Logistics and safety issues when con-
sidering PET/MR scans of premature infants can be
addressed by performing the scan using an MR-compa-
tible infant transport incubator which is available for
the PET/MR scanner.
PET image quality and resolution in a premature
infant of, i.e. 30 weeks’ gestational age should be ade-
quate since the unmyelinated white matter is the most
prominent tissue class of the brain and the gyral pattern
is relatively simple.59 The anatomical structures are suf-
ﬁciently developed to enable adequate VOIs to deter-
mine white and gray matter rCBF, even though the
brain volume is small and increases dramatically from
150mL at 29 weeks to 400ml at term.59 The volume of
the left ventricle in premature infant of 1 kg is approxi-
mately 1mL corresponding to a diameter of 14mm if
assuming a spherical shape,38 which would still allow
the measurement of central voxels that are not aﬀected
by the partial volume eﬀect.
Even though we were unsuccessful in acquiring ade-
quate ASL data, we believe that we have presented a
clinical neuropediatric tool for future PET/MRI in the
healthy or diseased child during the ﬁrst year of
infancy. In neonatal patients, particularly, PVL is a
target diagnosis, where current diagnostic methods
are challenged to adequately quantify CBF and char-
acterize the extent of the white matter damage and
relate it to anatomy. This should now be possible.
Furthermore, it would be a method of choice for
documenting hemodynamic insuﬃciency in the pre-
operative planning of infants suﬀering from early
onset Moya-Moya’s disease, a progressive obliterating
angiopathy of major supratentorial vascular territories
of the brain characterized by repeated transitory ische-
mic attacks (TIAs) and ischemic stroke.47
Also, PET/MRI may be used for independent sim-
ultaneous evaluation of new MRI perfusion techniques
using PET as the ‘golden’ standard. There are initia-
tives to render improved ASL sequences more widely
available. Furthermore, our method allows advanced
combinations of standard and modern MRI techniques
with molecular PET imaging, as have been shown in,
e.g. pediatric neurooncology.60,61
No previous studies of 15O-water PET rCBF in
healthy newborn infants have been done. We obtained
good quality images in four healthy newborns using a
new PET/MRI method with an IDIF. We used improved
diagnostic methods with a substantially lower radiation
dose than the few existing previous studies performed in
infants with pathology. The white/grey matter CBF ratio
was close to that measured in the healthy human adult
brain. The method may be useful as a ‘golden’ standard
for evaluating new MR-based methods as well as for
clinical research in speciﬁc disease states.
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